Are equity markets any good a pricing Covid-19?

Are equity markets any good a pricing Covid-19?

DWS | The recent pattern in European equity markets looks strikingly similar to what happened in Asia after the SARS outbreak. That could be a mixed blessing. What is going on in stock markets? How come major indices continue to climb despite rising numbers of Covid-19 infections? Five months ago is when we first asked ourselves these questions. Mid-February, to be precise. China had just revised the number of reported cases upwards by 14,800. Meanwhile, many major equity markets were reaching new highs. Back in February, we took a look back at the year 2003 and the outbreak of severe acute respiratory syndrome (SARS) as a reference point (see Chart of the Week as of 2/14/20). Though we advised for caution, the full extent of the pandemic was beyond our imagination back then. So was the economic damage that Covid-19 went on to cause. Nevertheless, equity markets have recovered nicely since their March lows. How do recent market developments compare to the latest infection numbers? Although the current pandemic has been many times more serious than the SARS outbreak, there is still a striking similarity in the pattern. On western stock exchanges, the sharp selloff began a good two weeks before the sharp rise in the number of Covid-19 infections, as our “Chart of the Week” shows on the basis of the European stock market (MSCI EMU Index). Stocks hit rock bottom about a week before the number of daily new infections peaked. The lead time was only a few days. Still, some ...
More on: thecorner.eu